At a daylong Digital Health Advisory Committee meeting, FDA, clinicians, payers, and developers wrestled with how generative AI mental health devices can expand access without compromising safety. Below is a recap of the daylong discussion. (Watch the replay here.)

AI Disclosure: This report was written in collaboration with generative AI, with specific direction, resources, editing, and review provided by me.

On November 6, the FDA’s Digital H...